|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date17 Jul 2006 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date03 Oct 2001 |
|
MechanismADRA2 antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.NL |
First Approval Date01 Mar 1994 |
100 Clinical Results associated with Organon USA LLC
0 Patents (Medical) associated with Organon USA LLC
100 Deals associated with Organon USA LLC
100 Translational Medicine associated with Organon USA LLC